Millipore Sigma Vibrant Logo

MABN2310-100UG Anti-C9orf72 peptide 5 Antibody, clone 5F6

MABN2310-100UG
100 μg  
価格を検索中…
価格が見つかりません
Minimum Quantity needs to be mulitiple of
Maximum Quantity is
弊社照会 詳細を表示 
値引
()
 
弊社照会
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

       

      お問合せください

      概要

      Replacement Information
      Description
      Catalogue NumberMABN2310-100UG
      DescriptionAnti-C9orf72 peptide 5 Antibody, clone 5F6
      Alternate Names
      • Guanine nucleotide exchange C9orf72
      Background InformationGuanine nucleotide exchange C9orf72 (UniProt: Q96LT7; also known as C9orf72) is encoded by the C9orf72 gene (Gene ID: 203228) in human. C9orf72 is a low abundant, cytoplasmic, highly soluble protein. The long isoform (481 amino acids) is shown to be the predominant form that is expressed in human brain. Expansion of a GGGGCC (G4C2) hexanucleotide repeat sequence in the non-coding region of human C9orf72 is the most common genetic abnormality in familial and sporadic frontotemporal dementia (FTD) and motor neuron disease (MND), with amyotrophic lateral sclerosis (ALS) as the most frequent form. The majority of normal human C9orf72 alleles carry less than 20 repeats, whereas large expansions consisting of hundreds or thousands of repeats lead to disease. C9orf72 generates three transcripts through alternative splicing that encode 2 protein isoforms; a long isoform of about 54 kDa (termed C9-L), corresponding to variants 2 and 3, and a short isoform of about 24 kDa (termed C9-S) corresponding to variant 1. Both isoforms are widely expressed, including kidney, lung, liver, heart, testis and several brain regions, including cerebellum, and frontal cortex. Both, C9-L and C9-S are reported to display distinct subcellular localizations in cerebellar Purkinje cells of both c9-ALS and nonc9-ALS cases. C9-L is shown to be spread diffusely throughout the cytoplasm, whereas C9- S is localized to the nuclear membrane of Purkinje cells of both c9-ALS and non-c9-ALS cases. Also, C9-L is shown to be present mainly in the high-salt Triton and urea-soluble fractions, whereas C9-S is shown to be abundant in both the low- and high-salt Triton fractions, indicating differences in their subcellular localizations. (Ref.: Frick, P., et al. (2018). Acta Neuropathol. Commun. 6(1); 72).
      References
      Product Information
      FormatPurified
      PresentationPurified rat monoclonal antibody IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Applications
      ApplicationAnti-C9orf72 peptide 5, clone 5F6, Cat. No. MABN2310, is a rat monoclonal antibody that detects Guanine nucleotide exchange C9orf72 and is tested for use in Immunofluorescence, Immunohistochemistry (Paraffin), and Western Blotting.
      Key Applications
      • Immunofluorescence
      • Immunohistochemistry (Paraffin)
      • Western Blotting
      Application NotesWestern Blotting Analysis: A representative lot detected C9orf72 peptide 5 in Western Blotting applications (Frick, P., et. al. (2018). Acta Neuropathol Commun. 6(1):72).

      Immunohistochemistry (Paraffin) Analysis: A representative lot detected C9orf72 peptide 5 in Immunohistochemistry applications (Frick, P., et. al. (2018). Acta Neuropathol Commun. 6(1):72).

      Immunofluorescence Analysis: A representative lot detected C9orf72 peptide 5 in Immunofluorescence applications (Frick, P., et. al. (2018). Acta Neuropathol Commun. 6(1):72).

      Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
      Biological Information
      ImmunogenOvalbumin-conjugated linear peptide corresponding to 20 amino acids from the N-terminal half (peptide 5) of human C9orf72.
      Clone5F6
      Concentration1 mg/mL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
      HostRat
      SpecificityClone 5F6 is a rat monoclonal antibody that specifically detects human C9orf72. It targets an epitope within the N-terminal half (peptide 5). It does not recognize murine C9orf72.
      IsotypeIgG1κ
      Species Reactivity
      • Human
      Species Reactivity NoteHuman.
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • C9orf72
      Purification MethodProtein G purified
      UniProt Number
      Molecular Weight~60 kDa observed; 54.33 kDa calculated. Uncharacterized bands may be observed in some lysate(s).
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blotting in human hippocampus tissue lysate.

      Western Blotting Analysis: 1 µg/mL of this antibody detected C9orf72 peptide 5 in human hippocampus tissue lysate.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 μg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      MABN2310-100UG 04061841844556

      Documentation

      Anti-C9orf72 peptide 5 Antibody, clone 5F6 (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      Anti-C9orf72 peptide 5 Antibody, clone 5F6 試験成績書(CoA)

      タイトルロット番号
      Anti-C9orf72 peptide 5, clone 5F6 - Q3437409 Q3437409

      参考資料

      参考資料の概要Pub Med ID
      Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers.
      Frick P, Sellier C, Mackenzie IRA, Cheng CY, Tahraoui-Bories J, Martinat C, Pasterkamp RJ, Prudlo J, Edbauer D, Oulad-Abdelghani M, Feederle R, Charlet-Berguerand N, Neumann M.
      Acta Neuropathol Commun  6(1)  72  2018

      概要を表示する
      30075745 30075745